Jay R. Luly Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months ago
Jay R. Luly has an estimated net worth of at least $11.8 million*, as of Oct. 29, 2025. They own 858,026 shares of ENTA stock. They have sold 79,543 shares of ENTA stock since 2021, for an estimated $2.7 million.
Jay R. Luly $ENTA SEC Form 4 Insider Trading
Jay R. Luly has filed a total of 11 insider trades in $ENTA since 2021. Their most recent trade was a sale of 4,743 shares, made on Dec 05, 2025. Their largest trade was a purchase of 45,000 shares, made on Feb 12, 2025. We estimate that they now own 858,026 shares of $ENTA, worth an estimated $9.1 million.
Insider Trading at $ENTA
There have been a total of 67 insider trades reported at $ENTA since 2021, with 45,000 shares purchased and 353,458 shares sold. The most active insider traders in $ENTA stock have been Nathalie Adda, Jay R. Luly, and Scott T. Rottinghaus. The most recent trade was a sale of 323 shares reported by Kathleen S. Capps (See Remarks), made on Dec 05, 2025.
History of Insider Stock Trades by Jay R. Luly
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ENTA
|
Sale | 4,743 | Dec 05, 2025 | Dec. 5, 2025, 7:41 p.m. |
ENTA
|
Purchase | 45,000 | Feb 12, 2025 | Feb. 12, 2025, 9:09 p.m. |
ENTA
|
Sale | 5,142 | Dec 06, 2024 | Dec. 10, 2024, 5:55 p.m. |
ENTA
|
Sale | 7,230 | Dec 05, 2023 | Dec. 6, 2023, 9:17 p.m. |
ENTA
|
Sale | 10,697 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
ENTA
|
Sale | 15,649 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
ENTA
|
Sale | 1,566 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
ENTA
|
Sale | 7,800 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
ENTA
|
Sale | 8,597 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
ENTA
|
Sale | 13,603 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
ENTA
|
Sale | 4,516 | Sep 15, 2021 | Sept. 16, 2021, 8 p.m. |
$ENTA Executives and Stock Owners with Insider Trades
-
Nathalie Adda, Sr. VP & Chief Medical Officer
-
Jay R. Luly, President and CEO
-
Scott T. Rottinghaus, Chief Medical Officer
-
Paul J Mellett, Treasurer and CFO
-
Tara Lynn Kieffer, Chief Product Strategy Officer
-
Brendan Luu, Chief Business Officer
-
Harry R. Iii Trout, See Remarks
-
Kathleen S. Capps, See Remarks
-
Yat Sun Or, Sr. VP & CSO
-
Yat Sun Or, Chief Scientific Officer
-
Tara Lynn Kieffer, Sr. VP, New Prod. Strat. & Dev
-
Paul J Mellett, Sr. VP, Finance & Admin. & CFO
-
Scott T. Rottinghaus, Sr. VP & CMO
-
Brendan Luu, Sr. VP, Business Dev.
-
Paul J Mellett, Chief Fin. & Admin Officer
-
Nathaniel S. Gardiner, Sr. VP & General Counsel
-
Yat Sun Or, Sr. VP, R&D & CSO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.